Popular:
AIM ImmunoTech Inc. (AIM)
Intrinsic Value
DCF Not Suitable for AIM
Market cap ($0.00B) below $1B threshold — DCF not reliable for small-cap/micro-cap stocks.
Alternative Approach:
Use relative valuation (P/E, P/S) vs. peer group.
AIM ImmunoTech Inc. (AIM) Intrinsic Value
DCF-based fair value calculation with Bear, Base, and Bull scenarios
Frequently Asked Questions
Is AIM stock undervalued or overvalued?
Insufficient data to compute DCF valuation for AIM. This typically occurs with negative FCF, early-stage companies, or financials where standard DCF models require modification.
What is AIM's intrinsic value?
Unable to calculate intrinsic value. DCF requires positive free cash flow and complete financial data. For banks/REITs, we substitute Net Income or FFO respectively.
How is AIM's fair value calculated?
Standard two-stage DCF with 5-year explicit forecast period and Gordon Growth terminal value. WACC estimated from sector averages and company beta. For AIM, insufficient data prevents full calculation—typically requires 3+ years of positive FCF history.